[{"Assets_0_Q3_USD":1544530000.0,"EarningsPerShareDiluted_3_Q3_USD":3.29,"EarningsPerShareDiluted_1_Q3_USD":1.05,"EarningsPerShareBasic_3_Q3_USD":3.35,"EarningsPerShareBasic_1_Q3_USD":1.07,"StockholdersEquityConverted_0_Q3_USD":-1363000.0,"StockholdersEquity_0_Q3_USD":-1604000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":87029000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":86756000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":88687000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":88453000.0,"NetIncomeLossConverted_3_Q3_USD":291393000.0,"NetIncomeLossConverted_1_Q3_USD":93251000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":264436000.0,"CommonStockSharesOutstanding_0_Q3_shares":86546000.0,"CommonStockSharesConverted_0_Q3_shares":105042000.0,"RevenuesConverted_1_Q3_USD":545448000.0,"RevenuesConverted_3_Q3_USD":1663856000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20181101"}]